Related Experiment Video
Updated: Mar 26, 2026

09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
11.8K
Cdk5r1 Overexpression Induces Primary β-Cell Proliferation.
Carrie Draney1, Amanda E Hobson1, Samuel G Grover1
1Nutrition, Dietetics and Food Science Department, College of Life Sciences, Brigham Young University, Provo, UT 84602, USA.
Journal of Diabetes Research
|January 21, 2016
Summary
Cyclin-dependent kinase 5 regulatory subunit 1 (Cdk5r1) promotes beta-cell proliferation and survival, offering potential for diabetes therapy by increasing functional beta-cell mass.
Area of Science:
- Endocrinology
- Cell Biology
- Molecular Biology
Background:
- Decreased beta-cell mass is characteristic of type 1 and type 2 diabetes.
- Islet transplantation is limited by the scarcity of suitable islets.
- Identifying pathways controlling beta-cell proliferation is crucial for diabetes treatment.
Purpose of the Study:
- To investigate Nkx6.1-independent mechanisms of beta-cell proliferation.
- To identify novel regulators of beta-cell mass.
- To explore therapeutic strategies for increasing functional beta-cell mass.
Main Methods:
- Expression analysis to identify Nkx6.1-independent pathways.
- Overexpression of Cdk5r1 in primary rat beta-cells.
- Assessment of beta-cell proliferation, insulin secretion, and apoptosis.
- Inhibition of Cdk5 kinase complex with roscovitine.
Main Results:
- Cdk5r1 is upregulated by Nr4a1 and Nr4a3, independent of Nkx6.1.
- Cdk5r1 overexpression induces beta-cell proliferation and maintains insulin secretion.
- Cdk5r1 protects beta-cells from etoposide and thapsigargin-induced apoptosis.
- Cdk5 kinase activity is essential for Cdk5r1-mediated beta-cell proliferation and pRb phosphorylation.
Conclusions:
- Activation of the Cdk5 kinase complex is sufficient to induce beta-cell proliferation.
- Cdk5r1 is a key mediator of beta-cell proliferation and survival.
- Targeting the Cdk5 pathway may represent a novel therapeutic approach for diabetes.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Cell Specific Gene Expression
16.9K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.9K
Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Mitogens and the Cell Cycle
8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway
6.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.3K

